ERAS Stock Analysis: Buy, Sell, or Hold?
ERAS - Erasca, Inc. Common Stock
$17.90
-0.63 (-3.40%)
▼
5d:
-5.04%
30d:
+33.88%
90d:
+5.23%
HOLD
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
28d
Smart Money Distribution
None View Scanner →
Strength: 5.2/10
Get Alerted When ERAS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ERAS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ERAS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ERAS is currently trading at $17.90, which is considered slightly high relative to its 30-day fair value range of $13.44 to $18.05.
Technical Outlook: Technically, ERAS is showing sideways momentum. Immediate support is located at $15.84, while resistance sits at $20.07. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: ERAS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.00 (+17.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ERAS is showing sideways momentum. Immediate support is located at $15.84, while resistance sits at $20.07. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: ERAS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.00 (+17.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$13.44 -
$18.05
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.1%
Protect Your Profits
Holding ERAS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading below Wall St target ($21.00)
- CAUTION: Recommendation downgraded due to -5.0% 5-day decline
Trading Range Analysis
30-Day Trading Range
$13.44 -
$18.05
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$15.84
Resistance Level
$20.08
Current Trend
Sideways
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-31.15
Wall Street Target
$21.00
(+17.3%)
Share & Embed Analysis
Last updated: July 13, 2026 6:01 PM ET
Data refreshes hourly during market hours. Next update: 7:01 PM
Data refreshes hourly during market hours. Next update: 7:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ERAS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ebun Garner
SELL
80000 shares
2026-04-01
Shannon Morris
SELL
20000 shares
2026-03-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
Advanced ERAS Option Strategies
Professional options setups generated by AI based on today's ERAS price and gamma walls.
